CellCarta (formerly Caprion – HistoGeneX) is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. With 20 years of experience providing services to the biopharma industry and a team of hundreds of scientists, including a high proportion of Ph.D., CellCarta has a strong expertise in complex assay development for clinical studies. CellCarta also offers integrated data solutions, including data management, bioinformatics, biostatistics, data interpretation, image analysis and AI/ML data interpretation. With a strong focus on Quality, CellCarta operates globally across 11 facilities located in Canada, USA, Belgium, Australia, and China.

Reveal Biosciences is a CellCarta company focused on data and AI applications in pathology and multi-omics. Reveal has created a new generation of Pathology Intelligence™ to advance research and improve patient outcomes globally. Reveal’s imageDx™ pathology platform combines cutting edge artificial intelligence (AI) with traditional histopathology to transform tissue biology into actionable insights. imageDx™ provides AI data analytics and cloud-based whole slide image management to Life Sciences and Healthcare. With a world class team of data and research scientists focused on addressing some of the biggest problems in healthcare, Reveal has developed a pipeline of AI-based digital assays for preclinical research, clinical trials, and diagnostics.